X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

VBIV

Closed

Vbi Vaccines Inc

0.018
+0.018 (0%)
Last Update: 06 Sep 2024 16:30:00
Yesterday: 0.
Day's Range: 0.0155 - 0.02
Send
When Written:
 
0.155
VBI Vaccines Inc. is a biopharmaceutical company that develops and commercializes vaccines for infectious diseases. The company's lead product candidate is a vaccine for hepatitis B, which is currently in Phase III clinical trials. VBI Vaccines also has a pipeline of other vaccine candidates, including a vaccine for cytomegalovirus (CMV) and a vaccine for glioblastoma multiforme (GBM), a type of brain cancer. The company's technology platform is based on virus-like particle (VLP) technology, which allows for the production of vaccines that mimic the structure of viruses without the infectious component. VBI Vaccines is headquartered in Cambridge, Massachusetts, and has operations in Ottawa, Canada.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:18.188.30.94
X